SequelSEC

America Great Health AAGH

Pharmaceutical Preparations · CIK 0001098009 · Fiscal year ends 0630

Revenue
$363.33K
Fiscal year ended 2026-03-31
Operating income
-$382.18K
Fiscal year ended 2026-03-31
Free cash flow
Unavailable
Fiscal year ended 2026-03-31

Valuation, from the filing

Public float$3.50BMarket value of stock held by non-affiliates, as stated on the cover page for 2015-12-31
Float per share$0.17Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2015-12-31, not today, and each multiple below it uses the figures for the fiscal year ending 2016-06-30 — the year that filing covered.

How this compares in its industry

Percentile among the Pharmaceutical Preparations filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
SBC / revenue0.0%0th
Current ratio0.06x4th
Gross margin86.6%76th
Revenue YoY growth32.9%70th
Operating margin-97.8%59th
Net margin-183.6%49th

America Great Health (AAGH) reported revenue of $363.33K and net income of $639.11K for the fiscal year ended 2026-03-31. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from America Great Health’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

America Great Health income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-31
Revenue$363.33K
Cost of revenue$114.17K
Gross profit$249.16K
Operating income-$382.18K
Net income$639.11K
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income$638.91K
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$631.34K
General & administrative$559.71K
Selling & marketingUnavailable

Balance

America Great Health balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-31
Cash & equivalentsUnavailable
Total assets$167.10K
Current assets$145.98K
Total liabilities$5.05M
Current liabilities$2.62M
Total equity incl. NCI-$4.88M
Temporary (mezzanine) equityUnavailable
Inventory$97.54K
Accounts receivable$0
GoodwillUnavailable
Long-term debt$2.42M
Accounts payableUnavailable

Cash flow

America Great Health cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-31
Operating cash flow-$352.84K
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$330.69K
Net change in cashUnavailable
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

America Great Health derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-31
Free cash flowUnavailable
Gross margin68.6%
Operating margin-105.2%
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio0.06x
Revenue YoY growth-5.1%
Net margin175.9%
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open AAGH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-06-22View SEC filing
10-Q · Filed 2026-06-04View SEC filing
10-K · Filed 2026-04-10View SEC filing
10-Q · Filed 2025-05-15View SEC filing
10-Q · Filed 2025-04-14View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.